跳至主要内容
临床试验/CTRI/2025/09/094335
CTRI/2025/09/094335尚未招募2 期

Comparative clinical evaluation of Shirishadi Kwath and Gojihwadi Kwath orally along with Vidaryadi Ghrita Nasya in Vataja Pratishyaya (Allergic rhinitis)

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月16日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
3) Kshavathu (Sneezing)

研究概览

简要总结

This study is a Comparative clinical evaluation of Shirishadi Kwath and Gojihwadi Kwath orally along with Vidaryadi Ghrita Nasya in Vataja Pratishyaya (Allergic rhinitis). The trial will be conducted on 60 patients attending the OPD/IPD of the Shalakya Tantra Department, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar. Patients will be randomly divided into two groups of 30 each: Both groups will receive Vidaryadi Ghrita Nasya as a common intervention for 7 days. In addition, Group A will be administered Shirishadi Kwath orally for 30 days, while Group B will be administered Gojihwadi Kwath orally for 30 days. Assessment will be done before and after treatment on the basis of subjective and objective parameters, with follow-up at 1 month after completion of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
10.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with classical signs & symptoms of Vataja Pratishyaya [Allergic Rhinitis] described as per ayurvedic and modern science
  • Patients between the age group of 10 years to 60 years.
  • Patients in related group who are fit for Nasya Karma / Nasya yogya vyakti.
  • Patient willing to participate in the study.

排除标准

  • Patients less than 10 years and above 60 years of age.
  • Patients who are contraindicated for Nasya Karma.
  • Patients with chronic infective respiratory diseases, other conditions like sinusitis, chronic rhinosinusitis, DNS requiring surgical intervention, nasal polyp, tumors etc.
  • Patient suffering from any systemic diseases like uncontrolled diabetes mellitus, uncontrolled hypertension, heart disease, cancer and receiving medication which may alter the results of study.

结局指标

主要结局

3) Kshavathu (Sneezing)

时间窗: Baseline (before treatment); End of treatment (4 weeks, primary time point)

4) Shirashool (Headache)

时间窗: Baseline (before treatment); End of treatment (4 weeks, primary time point)

5) Galataluoshtha Shosha (Dryness of throat)

时间窗: Baseline (before treatment); End of treatment (4 weeks, primary time point)

6) Swarabheda (Change of Voice)

时间窗: Baseline (before treatment); End of treatment (4 weeks, primary time point)

Assessment will be done on the basis of subjective parameters.

时间窗: Baseline (before treatment); End of treatment (4 weeks, primary time point)

Subjective Parameters

时间窗: Baseline (before treatment); End of treatment (4 weeks, primary time point)

1) Nasaavrodha (Nasal obstruction)

时间窗: Baseline (before treatment); End of treatment (4 weeks, primary time point)

2) Nasa Srava (Rhinorrhea)

时间窗: Baseline (before treatment); End of treatment (4 weeks, primary time point)

次要结局

  • Assessment will be done on the basis of objective parameters.(OBJECTIVE PARAMETERS)

研究者

发起方
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Shivani Sharma

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan

研究点 (1)

Loading locations...

相似试验